Intravesically administered BCG combined with IFN‐α vs intravesically administered BCG alone
Disease progression · patients with non‐muscle invasive bladder cancer
Intravesically administered BCG combined with IFN‐α showed no clear difference in progression compared with intravesically administered BCG alone (low certainty).
1 finding from 1 review
- Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating… 2017 · Cochrane Headline outcomes onlyRR 0.26 [0.04, 1.87]2 studies · 219 participantsLow